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PURPOSE: To report the case of a woman with a diagnosis of grade II (low grade) parosteal osteosarcoma with the
occurrence of myocardial metastasis 13 years after resection, and to present a review of the existing literature on the subject.
METHODS: Description of the case and review of the literature.
CONCLUSION: The review leads to the conclusion that the occurrence of metastasis from parosteal osteosarcoma can
occur in up to 38% of the cases, in spite of its relatively low aggressiveness. However, myocardial metastasis of a parosteal
osteosarcoma is an event that was not found in the literature.
DESCRIPTORS: Parosteal. Osteosarcoma. Heart. Myocardial. Metastasis.
INTRODUCTION
Parosteal osteosarcoma (POS) is an
uncommon, slow-growing variant of
osteosarcoma (OS) that occurs on the
surface of the bone, and its diagnosis
is obtained using specific criteria1. Its
evolution is relatively benign, it is
usually treated by wide resection with
good results, and it often does not re-
quire chemotherapy.
The metastatic form of the disease
may occur in up to 38% of the cases a
few months or many years after the ini-
tial treatment2. The low-grade type of
POS seldom metastasizes; on the other
hand, the dedifferentiated variant2-4
has high potential for distant metasta-
sis, with the lung being the most com-
mon site. However, 14 cases of patients
with cardiac OS metastases whose pri-
mary tumors were of the conventional
variety in all cases are reported in the
literature. This report describes a case
of POS in a female patient who was
initially treated by wide resection and
developed late myocardial metastasis,
and it also presents a review of the lit-
erature with regard to several aspects
related to the occurrence of cardiac
metastases in patients with OS.
DESCRIPTION OF THE CASE
A 26-year-old, white, female pa-
tient presented a slow-growing tumor
in the right arm over a period of 5
years. The tumor was resected at an-
other service, with no available infor-
mation on surgical pathology (SP)
findings.
Six months after the resection,
there was a relapse of the lesion, at
which time the patient sought our serv-
ice.
After a simple x-ray that showed
characteristics suggestive of POS (Fig.
1), the patient was biopsied, with the
corresponding SP findings confirming
a grade II POS (Fig. 2). The patient un-
derwent wide resection of the proximal
humerus and implantation of a non-
conventional polyethylene endopros-
thesis (Fig. 3). Chemotherapy was not
indicated since it was a low-grade le-
sion. Thirteen years later at the annual
follow-up exam, imaging exams re-
vealed thoracic nodules, one of which
was located in the cardiac topography
(Figs. 4 and 5). When the thoracotomy
was performed, 2 pulmonary nodules
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were resected, at which time a 6 cm
nodule was also discovered in the
myocardial region in the atrioventricu-
lar septum next to the marginal and di-
agonal arteries, which was considered
unresectable due to its location.
The SP examination of the lesions
yielded grade II POS material, with
characteristics similar to those of the
primary tumor (Fig. 6).
The authors chose not to adminis-
ter adjuvant treatment and decided on
a strict follow-up protocol, with sim-
ple x-rays and thorax tomography at
3- and 6-month intervals, respectively
(Fig. 7).
The patient is faring well 3 years
after the surgery without additional
symptoms or signs of tumor growth
(Fig. 7).
DISCUSSION
POS is a malignant tumor of the
bone tissue that was first described by
Greschckter & Copeland in 19515,
with an incidence corresponding to 1%
of all bone tumors and 4% of OS2,6-9.
The World Health Organization de-
Figure 1 - X-ray showing parosteal
osteosarcoma in proximal humerus.
Figure 2 - Photomicrograph of juxtacortical osteosarcoma showing trabeculae of osteoid and
osseous tissue and fibrous tissue with anaplastic cells (HE, orig. mag. X 200).
Figure 3 - X-ray showing the wide resection and endoprosthesis.
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fines growth on external surfaces,
medullar invasion of up to 25%, high
grade of differentiation, and low grade
of malignancy as its diagnostic crite-
ria1. The highest incidence of POS oc-
curs in the third and fourth decades of
life predominantly in women, and the
increase of local volume and pain are
its clinical manifestations2,3,6. The di-
agnosis is suggested by clinical and
radiographic findings and confirmed
by biopsy and SP findings. Histopa-
thology shows the presence of 3 com-
ponents, consisting of fibrous, osseous,
and cartilaginous tissues, with 3 grades
of histological differentiation10. Grades
I and II are characterized as low grade,
also called conventional POS. How-
ever, POS might have a high-grade
component (grade III). In such cases,
the term dedifferentiated has been
used. There can be dedifferentiation of
a tumor from low to high grade; this
is a complex process that could be re-
lated to several local relapses3,10-12.
Most cases manifest themselves at the
time of diagnosis as tumors of local
growth, and occurrences of initial
metastatic disease are rare, which dem-
onstrates the insidious development of
this type of tumor2-5.
Treatment of POS is based upon
the specific stage of the tumor and on
whether it is intracompartmental or
extracompartmental (I
a




which cortical and medullar invasion
of the bone tissue does not occur, a
transparietal resection can be per-
formed, with better functional results
and low rates of local relapse2, as long
as strict controls of the resection mar-
gins are observed. In extracompart-
mental cases (Ib), it is necessary to use
wide resections, followed by reconsti-
tution with homologous grafts or
endoprostheses. Amputation is rarely
indicated, and it is restricted to the
cases of large volume with several re-
lapses.
Later evolution to metastatic dis-
ease can occur in up to 38% of the pa-
tients, and metastasis is generally as-
sociated with cases of grade III POS2,
medullar invasion, and several local
relapses4. The occurrence of metastases
with conventional tumors (low grade)
is less frequent, and it is restricted to
less than 20% of the cases3. The main
site of metastases is the lung, with the
abdomen and the central nervous sys-
tem being reported less frequently2,3,7,8.
The period of latency between the
primary tumor and the occurrence of
metastases can vary from a few months
to many years2-4; survival following
metastasis varies from 6 to 32 months,
with an average of 16 months2.
The presence of cardiac metastases
is relatively rare, occurring in 3% to
10% of the cases, of which just 10%
will present clinical or radiological
manifestations that may suggest the
diagnosis14–19. The main histological
types of the cardiac metastases are
Figure 5 - Thoracic tomography showing cardiac topography of the nodule.
Figure 4 - Lung x-ray showing thoracic nodules.
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Figure 7 - The most recent thoracic tomography of the patient, showing stable disease 4 years
later.
Figure 6 - Photomicrograph of thoracic specimen, showing formation of osteoid and osseous
tissue (HE, orig. mag. X 100).
purposes, is the production of bone
tissue, which can be radiographically
demonstrated as a circumscribed lesion
with osseous density in the projection
of the cardiac region14,31,32. Trans-
esophageal echocardiography con-
firms the lesion, permitting visualiza-
tion of the extent of involvement as
well as any eventual secondary hemo-
dynamic repercussions23. Final diagno-
sis is provided by the surgical pathol-
ogy exam.
To the best of our knowledge, the
occurrence of cardiac metastases from
POS is not described in the literature.
In addition, POS is a low-grade tumor
with a low probability of causing sys-
temic disease, which is one of the rea-
sons for diagnosis after such extended
periods of latency. Campanacci reports
9 occurrences of metastases in 41 cases
of POS (21.9%), 4 of which were dis-
covered after latency periods of over
10 years (11.5-23 years). Of those
cases, 3 were grade II, 2 presented in-
volvement of the medullar channel,
and all of them had undergone at least
2 manipulations4.
The previously described charac-
teristics of low aggressiveness also ac-
count for the favorable prognosis for
this patient, even without resection,
which is considered by thoracic sur-
geons to be of high morbidity poten-
tial, and without adjuvant treatment.
One option would be heart transplan-
tation, but that was not indicated in
our case, since there was no evidence
of symptosis; additionally, having to
keep the patient under immunosup-
pression adds additional risk of mor-
bidity. The choice in this case was the
follow-up based on clinical and radio-
graphic parameters.
No evidence of cardiac or systemic
symptoms has been found up to the
time of the last evaluation 4 years
later, confirming the low aggressive-
ness of the lesion.
melanomas and carcinomas, especially
of the bronchiogenic type20.
Concerning cases of OS, there are
reports of several instances in which
cardiac metastases were diagnosed14,21–
29
. The diagnoses in most of those
cases were performed postmortem and
were associated with a significant con-
currence of pulmonary lesions30. The
preferential location in the heart is the
pericardium, but there are some reports
of involvement of the endocardium,
whereas infiltration of the myocardium
is extremely rare. The clinical manifes-
tations can be muted or can surface as
arrhythmias, cardiac failure, compres-
sion of the vena cava, and features that
are similar to those of the endocardi-
tis. However, a very useful specific
characteristic, in terms of diagnostic
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RESUMO
SANTOS-MACHADO TM e col. - Os-
teossarcoma parostal com metástase
miocárdica após 13 anos de segui-
mento. Rev. Hosp. Clín. Fac. Med.
S. Paulo 58(2):113-118, 2003.
OBJETIVOS: Os autores relatam
um caso de uma paciente do sexo fe-
minino, com diagnóstico de osteos-
sarcoma parostal grau II (baixo grau),
que evoluiu com a ocorrência de
metástase miocárdica 13 anos após a
ressecção do tumor e incluem uma re-
visão da literatura sobre o assunto.
MÉTODOS: Descrição do caso e
revisão da literatura.
CONCLUSÕES: A revisão leva à
conclusão que a existência de metás-
tases oriundas do osteossarcoma paros-
teal pode ocorrer em até 38 % dos ca-
sos, a despeito da sua relativa baixa
agressividade. No entanto, a metástase
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